|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| C12N 5/20 |
| (11) | Number of the document | 1729803 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04810631.4 |
| Date of filing the European patent application | 2004-11-08 | |
| (97) | Date of publication of the European application | 2006-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2010-09-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/037430 |
| Date | 2004-11-08 |
| (87) | Number | WO 2005/102387 |
| Date | 2005-11-03 |
| (30) | Number | Date | Country code |
| 557621 P | 2004-03-29 | US | |
| 557620 P | 2004-03-29 | US | |
| 557622 P | 2004-03-29 | US | |
| 842011 | 2004-05-07 | US | |
| 982357 | 2004-11-05 | US |
| (72) |
WILLIAMS, Marna, US
TSO, J. Yun, US
LANDOLFI, Nicholas F., US
LIU, Gao, US
|
| (73) |
Abbott Biotherapeutics Corp.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES |
| THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES |